Waterpipe (hookah) tobacco use in pregnancy: use, preferences and perceptions of flavours.
biomarkers
flavor
hookah
preferences
pregnancy
waterpipe
Journal
Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
30
01
2019
revised:
10
05
2019
accepted:
13
05
2019
pubmed:
20
7
2019
medline:
3
6
2021
entrez:
20
7
2019
Statut:
ppublish
Résumé
Waterpipe tobacco (WPT; hookah) use is common in pregnant and reproductive-age women. Sweet flavours contribute to the appeal of WPT and are a potential regulatory target. This study investigated use, preferences and perceptions of WPT flavours in pregnant WPT users, and the impact of flavour preferences on preconception/prenatal WPT use and exposure biomarkers. 58 pregnant WPT users (mean age=27 years) completed a detailed interview regarding their WPT flavours use, preferences and perceptions. Biomarkers of nicotine and carcinogen exposure (eg, cotinine, benzene, butadiene) were also collected. 55% of participants were dual/poly WPT users (ie, reported use of one or more other tobacco products in addition to WPT). Pregnant WPT users reported nearly exclusive use of flavoured WPT, with greater use of menthol/mint (68%) followed by fruit flavours (48%) (p<0.001), and greater preferences for fruit followed by menthol/mint flavours (ps<0.05). Harm perceptions did not differ among flavours. Compared with dual/poly WPT users, WPT-only users reported more total WPT use events, greater use of and preference for menthol/mint flavoured WPT (ps<0.001), and decreased exposure biomarkers (ps≤0.040). Preference for menthol/mint and fruit flavours predicted more flavoured WPT use events during preconception and pregnancy; preference for menthol/mint predicted detectable cotinine and benzene levels but not butadiene. This is the first study of WPT flavour use, preferences and perceptions in pregnant women. Use of and preference for menthol/mint and fruit WPT flavours in this vulnerable population could be considered in regulating WPT flavours to protect the health of women and children.
Identifiants
pubmed: 31320397
pii: tobaccocontrol-2019-054984
doi: 10.1136/tobaccocontrol-2019-054984
pmc: PMC6980448
mid: NIHMS1530619
doi:
Substances chimiques
Biomarkers
0
Flavoring Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
s62-s71Subventions
Organisme : NIDA NIH HHS
ID : R01 DA042484
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA036105
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: TE is a paid consultant in litigation against the tobacco industry and is named on a patent for a device that measures the puffing behaviour of electronic cigarette users.
Références
Tob Control. 2016 Nov;25(Suppl 2):ii4-ii13
pubmed: 27794065
Public Health Rep. 2016 Jan-Feb;131(1):76-85
pubmed: 26843673
PLoS One. 2011;6(12):e28864
pubmed: 22194931
BMC Public Health. 2011 Apr 19;11:244
pubmed: 21504559
Nicotine Tob Res. 2016 Apr;18(4):379-85
pubmed: 26014452
Nicotine Tob Res. 2013 Jan;15(1):231-7
pubmed: 22573726
Chemosens Percept. 2010 Mar;3(1):51-56
pubmed: 20352054
Eur J Cardiovasc Nurs. 2018 Jan;17(1):85-92
pubmed: 28671481
Med Princ Pract. 2008;17(6):435-9
pubmed: 18836270
Am J Addict. 2016 Dec;25(8):634-640
pubmed: 27706885
Prev Med. 2017 Nov;104:50-56
pubmed: 28789981
Fed Regist. 2016 May 10;81(90):28973-9106
pubmed: 27192730
Matern Child Health J. 2003 Sep;7(3):179-86
pubmed: 14509413
Biol Mass Spectrom. 1991 May;20(5):247-52
pubmed: 1883864
Am J Prev Med. 2015 Jun;48(6):742-6
pubmed: 25890683
PLoS One. 2018 Mar 15;13(3):e0194145
pubmed: 29543907
Tob Control. 2016 Nov;25(Suppl 2):ii32-ii39
pubmed: 27633764
Reprod Toxicol. 2012 Dec;34(4):529-37
pubmed: 22989551
Tob Control. 2015 Mar;24 Suppl 1:i60-i65
pubmed: 25550418
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Am J Epidemiol. 1998 Aug 15;148(4):375-83
pubmed: 9717882
Tob Use Insights. 2016 Jul 05;9:13-28
pubmed: 27398028
BMJ Open. 2015 Sep 09;5(9):e009497
pubmed: 26353876
Nat Rev Cancer. 2003 Oct;3(10):733-44
pubmed: 14570033
Harm Reduct J. 2011 Aug 30;8:24
pubmed: 21878112
Iran J Allergy Asthma Immunol. 2017 Dec;16(6):488-500
pubmed: 29338155
MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):542-7
pubmed: 24964880
Environ Health Perspect. 2005 Feb;113(2):192-200
pubmed: 15687057
BJOG. 2008 Jan;115(1):91-7
pubmed: 18053105
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):765-72
pubmed: 23462922
Int J Environ Res Public Health. 2017 Mar 23;14(4):
pubmed: 28333107
Am J Public Health. 2013 Nov;103(11):e21-3
pubmed: 24028247
Tob Control. 2015 Mar;24 Suppl 1:i13-i21
pubmed: 25618895
Addict Behav. 2004 Dec;29(9):1821-31
pubmed: 15530724
Addict Behav. 2019 Apr;91:21-29
pubmed: 30446262
Nicotine Tob Res. 2011 Feb;13(2):78-87
pubmed: 21127030
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Tob Control. 2015 Mar;24 Suppl 1:i3-i12
pubmed: 25298368
Health Promot Int. 2019 Dec 1;34(6):1157-1166
pubmed: 30412234
Am J Health Behav. 2010 May-Jun;34(3):275-85
pubmed: 20001185
Indian J Cancer. 2014 Dec;51 Suppl 1:S78-82
pubmed: 25526254
Am J Public Health. 1987 Nov;77(11):1435-8
pubmed: 3661797
Bull Menninger Clin. 2014 Summer;78(3):243-52
pubmed: 25247743
Am J Prev Med. 2009 Dec;37(6):518-23
pubmed: 19944918
Tob Control. 2015 Mar;24 Suppl 1:i31-i43
pubmed: 25661414
Asian Pac J Cancer Prev. ;18(2):495-502
pubmed: 28345836
Am J Health Behav. 2018 May 1;42(3):37-46
pubmed: 29663979
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2793-809
pubmed: 25416714
Tob Control. 2015 Mar;24 Suppl 1:i22-i30
pubmed: 25666550
Am J Public Health. 2014 Aug;104(8):1429-36
pubmed: 24922152
Tob Control. 2017 Nov;26(6):709-719
pubmed: 27872344
Am J Prev Med. 2017 Aug;53(2):139-151
pubmed: 28318902
Neurosci Biobehav Rev. 2017 Sep;80:382-393
pubmed: 28642071
PLoS One. 2018 Feb 9;13(2):e0192191
pubmed: 29425207
Nicotine Tob Res. 2014 Oct;16(10):1348-55
pubmed: 24891552
Pharmacol Rev. 2005 Mar;57(1):79-115
pubmed: 15734728
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
J Chromatogr. 1981 Jan 2;222(1):61-70
pubmed: 6783675
Lancet Oncol. 2007 Aug;8(8):679-80
pubmed: 17726789
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1055-66
pubmed: 24836469